Depression and Anxiety in Patients Undergoing Diagnostic Investigations for Head and Neck Cancers

1986 ◽  
Vol 149 (4) ◽  
pp. 491-493 ◽  
Author(s):  
A. D. M. Davies ◽  
C. Davies ◽  
M. C. Delpo

Patients attending a regional head and neck Oncology Unit were assessed for depression and anxiety (using the Leeds self-assessment scales) before diagnostic biopsy investigations. At the time of the assessments, neither patients nor investigators knew the biopsy results. Patients whose biopsies subsequently proved positive (showing the presence of a tumour) had significantly higher depression scores than those whose biopsies were negative. Differences in mean anxiety scores did not differ between groups. It is suggested that depression is part of the clinical picture of head and neck cancer.

Author(s):  
Wei-Ting Tseng ◽  
Yu Lee ◽  
Chi-Fa Hung ◽  
Pao-Yen Lin ◽  
Chih-Yen Chien ◽  
...  

2015 ◽  
Vol 24 (8) ◽  
pp. 894-900 ◽  
Author(s):  
Mohammad Farris Iman Leong Abdullah ◽  
Nik Ruzyanei Nik Jaafar ◽  
Hazli Zakaria ◽  
Rama Krsna Rajandram ◽  
Raynuha Mahadevan ◽  
...  

2021 ◽  
Vol 104 (2) ◽  
pp. 207-213

Objective: To evaluate the prevalence of depression and anxiety in head and neck cancer patients and investigate the relationship of the associating factors. Materials and Methods: A cross-sectional study with self-completed questionnaire was conducted. Univariate and multivariate analyses with logistic regression were performed to assess the associated factors. Results: Total of 293 patients (71.7% male, 28.3% female) were enrolled. The mean ± SD age was 58.25±14.28 years. The prevalence of anxiety was 17.75% and depression was 16.04%. Diagnostic time >12 month (adjusted OR 4.79, 95% CI 1.48 to 15.54, p=0.009), and perception of disfigurement (adjusted OR 4.68, 95% CI 1.42 to 15.38, p=0.011) were associated with anxiety. Education level had a direct positive correlation with anxiety prevention (adjusted OR 95% CI 0.13, 0.03 to 0.57, p=0.006 and adjusted OR 0.07, 95% CI 0.01 to 0.48, p=0.007 for education level lower Bachelor degree and Bachelor degree or higher, respectively). For depression, patient age >65 years (adjusted OR 4.09, 95% CI 1.6 to 10.46, p=0.003), group staging 4 (adjusted OR 3.12, 95% CI 1.2 to 8.08, p=0.019), and fatigue (adjusted OR 5.7, 95% CI 1.92 to 16.93, p=0.002) were related to depression. While married status was a protective factor of depression (adjusted OR 0.38, 95% CI 0.16 to 0.94, p=0.037). Conclusion: Diagnostic time >12 months, and perception of disfigurement were associated with anxiety. Age >65 years, group staging 4, and fatigue were related to depression. Keywords: Depression and anxiety, Head and neck cancer


2013 ◽  
Vol 127 (S2) ◽  
pp. S2-S7 ◽  
Author(s):  
I Gunawardena ◽  
J Fitzgerald ◽  
A Morley ◽  
D J Hussey ◽  
C M Woods ◽  
...  

AbstractBackground and methods:Head and neck cancer is the sixth most common cancer worldwide. Advances in management have not greatly altered overall survival. Over the last decade, there have been significant scientific advances in our knowledge of cell cycle regulation and the complex oncogenic processes. MicroRNAs are small, non-coding RNAs which are integral to the regulation of gene expression and which play a part in carcinogenesis. The literature on the role of microRNA in head and neck cancer is reviewed.Objective:To introduce the role and significance of microRNAs in head and neck cancer.Results:The possibilities of incorporating microRNAs into clinical practice are discussed, including their potential role in diagnosis, prognosis, prediction of metastatic spread, therapy and tumour surveillance.Conclusion:Discoveries in expression profiling of microRNA in head and neck oncology promise advancements in the diagnosis, prognosis and therapy of these cancers.


2020 ◽  
Vol 44 ◽  
pp. 101702
Author(s):  
Sanli Jin ◽  
Minghua Cong ◽  
Lichuan Zhang ◽  
Yujie Wang ◽  
Dan Qin ◽  
...  

1995 ◽  
Vol 112 (5) ◽  
pp. P130-P130
Author(s):  
W. Frederick McGuirt

Educational objectives: To understand the principles and technique of positron emission tomography (PET) scanning and to know when PET scans will be beneficial in the evaluation of patietns with head and neck cancer.


Sign in / Sign up

Export Citation Format

Share Document